发明名称 RNAi MODULATION OF MLL-AF4 AND USE THEREOF
摘要 <P>PROBLEM TO BE SOLVED: To clarify that, by using an RNAi for specifically inhibiting MLL-AF4 gene expression in t(4;11) cells, depletion of the fusion transcription MLL-AF4 regulates clone-forming ability and proliferation, and inducing apoptosis in t(4; 11) positive leukemia cells, and puts the take of the cell in the SCID mouse xenogenic transplantation model at a risk. <P>SOLUTION: There are provided compositions and methods for modulating the expression of the MLL-AF4 fusion gene, and more particularly downregulation of MLL-AF4 by chemically modified oligonucleotides. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2011254840(A) 申请公布日期 2011.12.22
申请号 JP20110208167 申请日期 2011.09.22
申请人 ALNYLAM PHARMACEUTICALS INC 发明人 HEIDENREICH OLAF;VORNLOCHER HANS-PETER;HADWIGER PHILIPP
分类号 C12N15/09;A61K31/7105;A61K31/713;A61P35/00;A61P35/02;A61P43/00;C12N5/078;C12N15/113;C12Q1/02;C12Q1/68 主分类号 C12N15/09
代理机构 代理人
主权项
地址